Cognition Therapeutics Statistics

Total Valuation

CGTX has a market cap or net worth of $89.64 million. The enterprise value is $79.36 million.

Market Cap	89.64M
Enterprise Value	79.36M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CGTX has 73.47 million shares outstanding. The number of shares has increased by 54.93% in one year.

Current Share Class	73.47M
Shares Outstanding	73.47M
Shares Change (YoY)	+54.93%
Shares Change (QoQ)	+3.01%
Owned by Insiders (%)	0.68%
Owned by Institutions (%)	18.16%
Float	72.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	11.28
P/TBV Ratio	12.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.07.

Current Ratio	1.54
Quick Ratio	1.38
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,308.69

Financial Efficiency

Return on equity (ROE) is -219.68% and return on invested capital (ROIC) is -211.32%.

Return on Equity (ROE)	-219.68%
Return on Assets (ROA)	-122.56%
Return on Invested Capital (ROIC)	-211.32%
Return on Capital Employed (ROCE)	-729.39%
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +114.56% in the last 52 weeks. The beta is 1.00, so CGTX's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+114.56%
50-Day Moving Average	0.54
200-Day Moving Average	0.51
Relative Strength Index (RSI)	78.15
Average Volume (20 Days)	6,621,717

Short Selling Information

The latest short interest is 5.32 million, so 7.24% of the outstanding shares have been sold short.

Short Interest	5.32M
Short Previous Month	7.41M
Short % of Shares Out	7.24%
Short % of Float	7.29%
Short Ratio (days to cover)	0.30

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.94M
Pretax Income	-31.08M
Net Income	-32.99M
EBITDA	-52.88M
EBIT	-52.94M
Earnings Per Share (EPS)	-$0.63

Full Income Statement

Balance Sheet

The company has $10.74 million in cash and $468,000 in debt, giving a net cash position of $10.28 million or $0.14 per share.

Cash & Cash Equivalents	10.74M
Total Debt	468,000
Net Cash	10.28M
Net Cash Per Share	$0.14
Equity (Book Value)	7.03M
Book Value Per Share	0.11
Working Capital	6.69M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.73 million and capital expenditures -$1,000, giving a free cash flow of -$30.73 million.

Operating Cash Flow	-30.73M
Capital Expenditures	-1,000
Free Cash Flow	-30.73M
FCF Per Share	-$0.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.93%
Shareholder Yield	-54.93%
Earnings Yield	-36.81%
FCF Yield	-34.29%

Analyst Forecast

The average price target for CGTX is $2.83, which is 131.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.83
Price Target Difference	131.97%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-28.28%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1